Antifracture Efficacy of 5- or 10-Yearly Zoledronate in Women Aged 50 to 60 Years: Secondary Analyses of a Randomized Trial - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Efficacy of Zoledronate Administered Every 5 or 10 Years for Fracture Prevention in Women Aged 50 to 60: Insights from Secondary Analyses of a Randomized Study

  • By

  • Mark J Bolland

  • Zaynah Nisa

  • Anna Mellar

  • Chiara Gasteiger

  • Veronica Pinel

  • Borislav Mihov

  • Sonja Bastin

  • Andrew Grey

  • Ian R Reid

  • Greg Gamble

  • Anne Horne

  • October 18, 2025

Share

Original Source(s)

Antifracture Efficacy of 5- or 10-Yearly Zoledronate in Women Aged 50 to 60 Years: Secondary Analyses of a Randomized Trial

  • by Mark J Bolland, Zaynah Nisa, Anna Mellar, Chiara Gasteiger, Veronica Pinel, Borislav Mihov, Sonja Bastin, Andrew Grey, Ian R Reid, Greg Gamble, Anne Horne

  • October 18, 2025

Related Content

Body composition-derived principal components partially explain sex and age effects on bone mineral density in type 2 diabetes mellitus

Simplified Bone Age Method May Aid Review

Single-bone approach showed close agreement with Greulich-Pyle assessments in adolescents, particularly among experienced raters

An interpretable deep concatenated architecture for osteoporosis detection using enhanced knee radiographs